PTA Balloon Catheter Market Share, Size, Trends, Industry Analysis Report, By Material (Nylon, Polyurethane, Others); By Application; By End Use; By Region; Segment Forecast, 2024- 2032
- Published Date:Mar-2024
- Pages: 114
- Format: PDF
- Report ID: PM4667
- Base Year: 2023
- Historical Data: 2019 – 2022
Report Outlook
- Global PTA balloon catheter market size was valued at USD 1.99 billion in 2023.
- The market is anticipated to grow from USD 2.11 billion in 2024 to USD 3.63 billion by 2032, exhibiting the CAGR of 7.0% during the forecast period.
Market Introduction
The expanding elderly population is a key factor propelling the growth of the PTA (Percutaneous Transluminal Angioplasty) balloon catheter market. With advancements in healthcare and increased life expectancy, the prevalence of age-related conditions like Peripheral Artery Disease (PAD) rises. Elderly individuals, susceptible to vascular issues due to reduced activity and chronic illnesses, benefit from PTA balloon catheters. These devices facilitate minimally invasive procedures, restoring blood flow in narrowed arteries effectively.
In addition, companies operating in t9he market are introducing new products to expand market reach and strengthen their presence.
To Understand More About this Research:Request a Free Sample Report
- For instance, in March 2022, Nipro Medical Corporation introduced the latest iteration of the Cronus HP PTA Balloon Catheter to the U.S. market. Cronus HP is an advanced percutaneous transluminal angioplasty (PTA) balloon catheter designed for high-pressure applications. It is specifically intended for use in various arterial sites, including popliteal, femoral, iliac, and renal arteries, as well as for treating arteriovenous fistulas (AVF).
Technological advancements in catheter design are driving growth in the PTA balloon catheter market. Innovations in materials, coatings, and manufacturing techniques enhance catheter performance and effectiveness. For instance, hydrophilic coatings reduce friction, improving procedural efficiency and patient comfort. Low-profile balloon designs allow access to smaller vessels and complex anatomies, expanding the applicability of PTA procedures. Additionally, advancements in inflation technologies enable precise control and optimization of balloon expansion, leading to improved outcomes and reduced complications.
Industry Growth Drivers
Rising prevalence of peripheral artery disease is projected to spur the product demand
The PTA balloon catheter market is witnessing growth due to the escalating prevalence of Peripheral Artery Disease (PAD). PAD, characterized by arterial narrowing, is on the rise globally, attributed to aging populations, sedentary lifestyles, and conditions like diabetes and obesity. PTA balloon catheters are instrumental in minimally invasive procedures to restore blood flow in affected arteries. By inflating a balloon to widen narrowed arteries, they alleviate PAD symptoms such as leg pain. With the increasing burden of PAD, there's a growing demand for PTA balloon catheters, fueling market expansion to meet the needs of patients with peripheral artery disease.
Growing preference for minimally invasive procedures is expected to drive PTA balloon catheter market growth
The PTA balloon catheter market is expanding due to the rising preference for minimally invasive procedures. These catheters offer less disruptive alternatives for treating vascular conditions like peripheral artery disease and coronary artery disease. With smaller incisions, reduced complications, and quicker recovery times compared to surgery, they appeal to both patients and healthcare providers. Additionally, advancements in catheter design, including improved materials and coatings, enhance treatment precision. This trend towards minimally invasive interventions is driving significant growth in the PTA balloon catheter market, meeting the increasing demand for less invasive options in vascular procedures.
Industry Challenges
High cost of procedures is likely to impede the market growth
The PTA balloon catheter market faces a significant limitation due to the high cost of procedures. While these catheters offer effective treatment for vascular conditions like PAD and CAD, associated costs can burden patients and healthcare systems. Expenses include catheter prices, hospitalization, physician fees, imaging tests, and follow-up care. Some patients require multiple procedures, further elevating costs. Consequently, the financial barrier may deter patients or prompt providers to explore alternative treatments.
Report Segmentation
The PTA balloon catheter market analysis is primarily segmented based on material, application, end use, and region.
|
By Material |
By Application |
By End Use |
By Region |
|
|
|
|
To Understand the Scope of this Report:Speak to Analyst
By Material Analysis
Nylon segment held significant revenue share in 2023
The nylon segment held significant revenue share in 2023. Renowned for strength and durability, nylon withstands high-pressure inflation during procedures, ensuring reliability. Its flexibility aids in navigating vessels with precision, enhancing success rates. Additionally, nylon's low-profile design enables access to small vessels and complex anatomies. With a smooth surface, it minimizes friction during navigation, reducing the risk of vessel injury. Moreover, nylon's cost-effectiveness compared to alternatives makes it accessible to healthcare providers and patients.
By Application Analysis
Peripheral artery disease segment held significant revenue share in 2023
The peripheral artery disease segment held a significant revenue share in 2023. PAD is a widespread condition affecting a large population globally, particularly as risk factors such as diabetes, obesity, and aging increase. The rise in minimally invasive procedures for PAD treatment drives the demand for PTA balloon catheters, as they offer effective arterial dilation and restoration of blood flow. Additionally, advancements in catheter design and technology specifically tailored for PAD interventions enhance treatment outcomes. Furthermore, the growing prevalence of PAD in emerging markets contributes to the segment's revenue share as healthcare infrastructure improves and access to treatment expands.
By End Use Analysis
Hospitals and clinics segment held a significant revenue share in 2023
The hospitals and clinics segment held a significant revenue share in 2023. These facilities conduct a large volume of PTA balloon catheter procedures, serving diverse patients with arterial diseases. Equipped with specialized departments and advanced technologies, they offer effective treatment options for conditions like Peripheral Artery Disease (PAD). Additionally, hospitals and clinics act as referral centers for complex cases, expanding their patient pool. Their established relationships with insurance providers ensure reimbursement for procedures, encouraging patient referrals.
Regional Insights
North America region accounted for a significant market share in 2023
In 2023, the North America region accounted for a significant market share. Its advanced healthcare infrastructure, coupled with a high prevalence of cardiovascular diseases like PAD and CAD, drives demand for PTA balloon catheters. Technological advancements in catheter design and materials further enhance outcomes. With substantial healthcare expenditure, the region has the financial capability to invest in advanced medical devices. Stringent regulatory standards ensure the safety and efficacy of these devices. Additionally, the presence of key market players and a strong clinical research environment contribute to North America's dominance in the PTA balloon catheter market.
Asia-Pacific is expected to experience significant growth during the forecast period owing to the rising prevalence of peripheral artery disease driven by lifestyle changes and aging populations. Improving healthcare infrastructure facilitates the adoption of advanced treatments like PTA balloon catheters. Additionally, the rapidly aging population in the region contributes to the demand for PAD interventions. Government initiatives promoting healthcare reforms and the adoption of advanced medical technologies further boost market growth in the Asia-Pacific region.
Key Market Players & Competitive Insights
The PTA balloon catheter market encompasses a wide range of participants, and the anticipated entry of new competitors is set to heighten competition. Established frontrunners consistently upgrade their technologies to sustain a competitive edge, prioritizing efficacy, dependability, and safety. These companies focus on strategic initiatives like forging partnerships, enhancing product offerings, and engaging in cooperative ventures. Their goal is to surpass rivals in the sector, securing a notable PTA balloon catheter market share.
Some of the major players operating in the global PTA balloon catheter market include:
- Abbott Laboratories
- Andratec
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Biotronik
- Boston Scientific Corporation
- Cardinal Health, Inc.
- Cook Medical Inc.
- Endocor GmbH
- Medtronic plc
- Merit Medical Systems, Inc.
- Natec Medical Ltd.
- Philips
- Surmodics, Inc.
- Terumo Corporation
Recent Developments
- In June 2023, Cook Medical unveiled expanded size options and locations for its Advance Serenity hydrophilic percutaneous transluminal angioplasty balloon catheter product range. This device, utilized by interventionalists, caters to both below- and above-the-knee procedures aimed at treating patients with peripheral artery disease (PAD).
- In June 2023, BIOTRONIK introduced a limited release of its multifunctional peripheral catheter, Oscar (One Solution: Cross. Adjust. Restore). This catheter is specifically intended for dilating stenotic segments in peripheral vessels.
- In May 2022, Medtronic revealed that the U.S. Food and Drug Administration approved the IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. This drug-coated balloon (DCB) is indicated for treating peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries through interventional procedures.
Report Coverage
The PTA balloon catheter market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, materials, applications, end uses, and their futuristic growth opportunities.
PTA Balloon Catheter Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 2.11 billion |
|
Revenue forecast in 2032 |
USD 3.63 billion |
|
CAGR |
7.0% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2024 to 2032 |
|
Segments covered |
|
|
Regional scope |
|
|
Competitive Landscape |
|
|
Report Format |
|
|
Customization |
Report customization as per your requirements with respect to countries, region and segmentation. |
FAQ's
The global PTA Balloon Catheter market size is expected to reach USD 3.63 billion by 2032.
Key players in the market are B. Braun Melsungen AG, Becton, Dickinson and Company, Biotronik, Boston Scientific Corporation
North America contribute notably towards the global PTA Balloon Catheter Market
Global PTA balloon catheter market exhibiting the CAGR of 7.0% during the forecast period.
The PTA Balloon Catheter Market report covering key segments are material, application, end use, and region.
